Jeremie Boucher speaking — Photo: Johan Wingborg

New publication by Jeremie Boucher

Published

4 December 2020

at

The Wallenberg Centre for Molecular and Translational

WCMTM and AstraZeneca researcher Jeremie Boucher has a new publication in the journal Science Advances. Together with researchers at the Universidade Estadual de Campinas, he has investigated how enoxacin, a molecular antibiotic, can modify metabolic pathways linked to obesity.

About Jeremie Boucher Group

Jeremie Boucher, PhD, Adjunct Senior Lecturer (Associate Professor), aims to identify novel targets and pathways for the treatment of obesity and type 2 diabetes. He is also employed as a Principal Scientist at AstraZeneca, where he is coordinating and driving the early discovery programs for the treatment of metabolic diseases. This constitutes a unique opportunity to quickly translate the research findings of his lab into potential medicine to improve patients’ life.

More information information about Jeremie Boucher Group:

https://www.gu.se/en/research/jeremie-boucher

The publication can be found here:

https://advances.sciencemag.org/content/6/49/eabc6250

Area

Health and

medicine